Literature DB >> 8264698

AAEM minimonograph #41: neuromuscular diseases associated with HIV-1 infection.

D J Lange1.   

Abstract

Neuromuscular diseases occur in as many as 50% of patients infected with human immunodeficiency virus type 1 (HIV-1). All forms of neuromuscular disease have been reported, including axonal neuropathy, demyelinating neuropathy, mononeuropathy multiplex, polyradiculitis, ALS-like syndromes, disorders of neuromuscular transmission, myopathy, and toxic neuropathies due to medication side effects. Neuromuscular disease is often the presenting manifestation of HIV-1 infection. Infection with cytomegalovirus (CMV) is associated with different types of neuropathy including mononeuritis multiplex and polyradiculopathy. There is effective treatment for many of the associated disorders including chronic inflammatory demyelinating neuropathy, CMV-mediated neuropathies, and myopathy. Treatment of CMV-mediated mononeuropathy multiplex may be life saving. The different neuromuscular syndromes associated with different stages of HIV-1 infection may be due, in part, to different levels of immunocompetence.

Entities:  

Mesh:

Year:  1994        PMID: 8264698     DOI: 10.1002/mus.880170104

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

1.  Cytomegalovirus polyradiculopathy in HIV-infected patients.

Authors:  P A Meier; K T Stephan; S P Blatt
Journal:  J Gen Intern Med       Date:  1996-01       Impact factor: 5.128

2.  Lymphoma, paraproteinaemia, and neuropathy.

Authors:  J H Wokke; J H Morris; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

Review 3.  Recent advances in the neurology of HIV infection.

Authors:  R K Petty
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

4.  A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies.

Authors:  K Hahn; G Arendt; J S Braun; H-J von Giesen; I W Husstedt; M Maschke; M E Straube; E Schielke
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 5.  [HIV-associated neuropathies].

Authors:  K Hahn; I W Husstedt
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

Review 6.  [Epidemiology and therapy of pain and depression during HIV and AIDS].

Authors:  I W Husstedt; D Reichelt; F Kästner; S Evers; K Hahn
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.